News Sentiment

ELUT sentiment intelligence

Elutia Inc. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 0.96 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

78/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+3.3% over one week, +0.3% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Elutia Inc. (ELUT) Bounces From Support, Tests Key Resistance at $1.01 - RVOL Breakout

Market Reaction

Balanced read

58/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 78/100 classification
One-week reaction 3.3% Price confirming higher
Trend fit Trend inactive 0.3% over four weeks
Fair value -58.1% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 6
Neutral 45
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 12
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Market source 12
Sahm 3
dars.gov.et 2
GlobeNewswire 2
StockStory 2
The Globe and Mail 2
富途牛牛 1

Event Lens

What the news is about

Classified themes
Market update 26
Earnings 23
Regulatory and legal 2
Analyst action 1
Balance sheet 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
Stock Titan Direct company coverage

Elutia (NASDAQ: ELUT) Q1 loss deepens while NXT-41 pipeline and margins progress

Elutia Inc. (NASDAQ: ELUT) reported a wider net loss of $7.5 million in Q1 2026, despite slightly higher revenue of $3.1 million, as the company continues to invest in its drug-eluting biomatrix platform. Gross margins improved significantly, with GAAP at 57.9% and adjusted at 66

Tone
Neutral 50/100
Event
Earnings
Published
14 May 2026 20:09
Source
Stock Titan
Sahm Direct company coverage

Elutia Reports Q1 2026 Results: Full Earnings Call Transcript

Elutia reported increased net sales and gross margin in Q1 2026, driven by advancements in its NXT41 regulatory program and commercialization efforts for breast reconstruction. The company is confident about future FDA clearances for NXT41 and NXT41X, which target a $1.5 billion

Tone
Positive 75/100
Event
Earnings
Published
14 May 2026 16:09
Source
Sahm
Stock Titan Direct company coverage

Elutia (NASDAQ: ELUT) seeks approval for larger equity plan and board slate

Elutia Inc. (NASDAQ: ELUT) is asking stockholders to approve several proposals at its annual meeting on June 11, 2026. Key items include the re-election of two Class III directors, ratification of PricewaterhouseCoopers LLP as the 2026 auditor, and an amendment to the 2020 Incent

Tone
Neutral 50/100
Event
Regulatory and legal
Published
22 Apr 2026 21:09
Source
Stock Titan
Stock Titan Direct company coverage

Elutia Announces $13.26 Million Registered Direct Offering

Elutia has announced a $13.26 million registered direct offering, selling 3,175,000 shares of its Class A common stock at $3.40 per share and 725,000 prefunded warrants at $3.399 per warrant. The proceeds will be used for working capital and general corporate purposes. Lake Stree

Tone
Negative 31/100
Event
Market update
Published
16 Apr 2026 03:09
Source
Stock Titan
Stock Titan Direct company coverage

Elutia (ELUT) director receives 6,250 shares as RSUs vest, holding 125,000

Elutia (ELUT) director Guido J. Neels received 6,250 shares of Class A Common Stock due to the vesting of restricted stock units (RSUs) on December 10, 2025. These shares were part of a 25,000 RSU grant that vests in four equal installments. Following this transaction, Neels dire

Tone
Neutral 50/100
Event
Market update
Published
14 Apr 2026 11:39
Source
Stock Titan
The Globe and Mail Direct company coverage

Elutia Adopts 2026 Inducement Equity Award Plan

Elutia Inc. has adopted its 2026 Inducement Award Plan, authorizing up to 2,000,000 shares of Class A common stock for new hires to attract, retain, and motivate talent without requiring shareholder approval under Nasdaq rules. The plan allows the Compensation Committee to admini

Tone
Neutral 50/100
Event
Regulatory and legal
Published
03 Apr 2026 10:10
Source
The Globe and Mail
The Globe and Mail Direct company coverage

Elutia Warns of Ongoing Nasdaq Delisting Risk Despite Recent Compliance Win

Elutia Inc. (ELUT) faces a new ongoing risk of Nasdaq delisting despite recently regaining compliance with minimum bid price and market value standards. Failure to meet future Nasdaq criteria could lead to reduced trading liquidity, pressure on the share price, and hinder the com

Tone
Negative 30/100
Event
Balance sheet
Published
28 Mar 2026 20:10
Source
The Globe and Mail